GbS Global Biopharma
Gb Sciences is a dedicated plant-based research and biopharmaceutical drug development company focused on creating patented formulations of plant-inspired, minimum essential mixtures for use as prescription medications. They leverage AI technology and collaborate with international research partners to develop innovative treatments for neurodegenerative disorders, inflammatory conditions, and other health issues.
Industries
Nr. of Employees
small (1-50)
GbS Global Biopharma
200-900 Morrison Drive Ottawa, Ontario, CANADA
Patents
TRPV1 activation-modulating complex mixtures of cannabinoids and/or terpenes
US-11260044-B2
View DetailsCannabinoid-containing complex mixtures for the treatment of mast cell-associated or basophil-mediated inflammatory disorders
US-10857107-B2
View Details
TRPV1 activation-modulating complex mixtures of cannabinoids and/or terpenes
US-11260044-B2
View DetailsCannabinoid-containing complex mixtures for the treatment of mast cell-associated or basophil-mediated inflammatory disorders
US-10857107-B2
View DetailsProducts
Pipeline of plant-derived therapeutic candidates (late preclinical)
Multiple therapeutic candidates derived from plant-based mixtures in late preclinical development targeting neurodegenerative disorders, chronic/neuropathic pain, cardiovascular disease, and inflammatory conditions.
AI-driven drug discovery platform for plant actives
A software-driven platform that analyzes ethnobotanical and biochemical data to predict efficacious combinations of plant-derived active ingredients and generate candidate APIs.
Oral delivery technologies for plant-derived medicines
Oral formulation approaches and delivery methods intended to enable standardized dosing and preserve activity of botanical-derived therapeutic mixtures.
Retail natural health products
Consumer-facing natural health products derived from botanical formulations, distributed through multiple retail channels (mentioned without product detail).
Pipeline of plant-derived therapeutic candidates (late preclinical)
Multiple therapeutic candidates derived from plant-based mixtures in late preclinical development targeting neurodegenerative disorders, chronic/neuropathic pain, cardiovascular disease, and inflammatory conditions.
AI-driven drug discovery platform for plant actives
A software-driven platform that analyzes ethnobotanical and biochemical data to predict efficacious combinations of plant-derived active ingredients and generate candidate APIs.
Oral delivery technologies for plant-derived medicines
Oral formulation approaches and delivery methods intended to enable standardized dosing and preserve activity of botanical-derived therapeutic mixtures.
Retail natural health products
Consumer-facing natural health products derived from botanical formulations, distributed through multiple retail channels (mentioned without product detail).
Services
Joint research and development collaborations focused on plant-derived therapeutic discovery, lead optimization, and late preclinical advancement.
Joint research and development collaborations focused on plant-derived therapeutic discovery, lead optimization, and late preclinical advancement.
Expertise Areas
- Plant-based drug discovery
- AI-driven combination discovery
- Preclinical development and animal models
- Formulation and oral drug delivery
Key Technologies
- AI-driven drug discovery
- High-throughput screening (HTS)
- Preclinical animal disease models
- Standardized botanical formulation